Anti-tumor agent comprising cytidine derivative and carboplatin

Provision of a novel combined therapy with ECyd, which therapy exhibits remarkable antitumor effect and gives less adverse effects. The invention provides an antitumor agent containing, in combination, 1-(3-C-ethynyl-beta-D-ribopentofuranosyl)cytosine or a salt thereof and carboplatin.

Saved in:
Bibliographic Details
Main Author KAZUNO HIROMI
Format Patent
LanguageEnglish
Published 19.11.2013
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Provision of a novel combined therapy with ECyd, which therapy exhibits remarkable antitumor effect and gives less adverse effects. The invention provides an antitumor agent containing, in combination, 1-(3-C-ethynyl-beta-D-ribopentofuranosyl)cytosine or a salt thereof and carboplatin.
AbstractList Provision of a novel combined therapy with ECyd, which therapy exhibits remarkable antitumor effect and gives less adverse effects. The invention provides an antitumor agent containing, in combination, 1-(3-C-ethynyl-beta-D-ribopentofuranosyl)cytosine or a salt thereof and carboplatin.
Author KAZUNO HIROMI
Author_xml – fullname: KAZUNO HIROMI
BookMark eNrjYmDJy89L5WSwd8wrydQtKc3NL1JITE_NK1FIzs8tKMoszsxLV0iuLMlMycxLVUhJLcosSyzJLEtVSMxLUUhOLErKL8gBCuTxMLCmJeYUp_JCaW4GBTfXEGcP3dSC_PjU4oLE5NS81JL40GALUwszUzNDJyNjIpQAAIDPMww
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Forestry
Agriculture
ExternalDocumentID US8586561B2
GroupedDBID EVB
ID FETCH-epo_espacenet_US8586561B23
IEDL.DBID EVB
IngestDate Fri Jul 19 14:40:21 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US8586561B23
Notes Application Number: US20090934772
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20131119&DB=EPODOC&CC=US&NR=8586561B2
ParticipantIDs epo_espacenet_US8586561B2
PublicationCentury 2000
PublicationDate 20131119
PublicationDateYYYYMMDD 2013-11-19
PublicationDate_xml – month: 11
  year: 2013
  text: 20131119
  day: 19
PublicationDecade 2010
PublicationYear 2013
RelatedCompanies TAIHO PHARMACEUTICAL CO., LTD
KAZUNO HIROMI
RelatedCompanies_xml – name: KAZUNO HIROMI
– name: TAIHO PHARMACEUTICAL CO., LTD
Score 2.9187331
Snippet Provision of a novel combined therapy with ECyd, which therapy exhibits remarkable antitumor effect and gives less adverse effects. The invention provides an...
SourceID epo
SourceType Open Access Repository
SubjectTerms AGRICULTURE
ANIMAL HUSBANDRY
BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES
FISHING
FORESTRY
HUMAN NECESSITIES
HUNTING
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PEST REPELLANTS OR ATTRACTANTS
PLANT GROWTH REGULATORS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTSTHEREOF
TRAPPING
Title Anti-tumor agent comprising cytidine derivative and carboplatin
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20131119&DB=EPODOC&locale=&CC=US&NR=8586561B2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LTwIxEJ4QND5OihrxlR4Mt42ubFk4bAjsQogJjwgYbmS6D7MHu2QpGv-902ZBL3pr2qRpJ_3m62PmK8C9-9RI3CRMLKKSR8vBumNhYocWIrotEUVYN2I6w1FjMHeeF3xRgnSbC2N0Qj-NOCIhKiS8K-OvVz-XWIGJrVw_iJSqsnZ_5gW14nSstWMIgUHX603Gwdiv-b43n9ZGL16TN2nnYnfJW-_pXbSW2e-9dnVSyuo3o_RPYH9CnUl1CqVYVuC485YXKhhxBQ797TdsFTjQn2cWxWHxEE7FApPrM2h3pEottXnPcoY6UYrpMHHCLpESC79USuwUs4hW2ocR-WYoIxZiLrKVjoOT58D6vZk_sGiIy505lvPpbjL1CyjLTMaXwBpIzg25G9vCdhK0BcdQX-9x0eKCO24Vqn92c_VP2zUcabvq9Du7dQNllW_iW-JhJe6MBb8B7ICOUA
link.rule.ids 230,309,786,891,25594,76904
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LTwIxEJ4QNKInRY347MFw2-i6WxYOGwK7EFReETDcSLsPswe7ZCka_73TZkEvemvapGkn_ebrY-YrwK3zUIudOIgNpJJ7w2aWbbDYDAzGmNPgYcgsLaYzGNZ6M_tpTucFSDa5MFon9FOLIyKiAsS71P56-XOJ5evYytUdT7AqbXanrl_NT8dKOwYR6Lfdznjkj7yq57mzSXX44tZpHXcuZhu99Y6DJ0Ils995bauklOVvRukewu4YOxPyCAqRKMNB6y3LVTCiMpS8zTdsZdhTn2fmxUH-EI7FHJOrY2i2hEwMuX5PM8JUohRRYeKIXSQlEnzJBNkpIiGutA8t8k2YCEnAMp4uVRycOAHS7Uy9noFDXGzNsZhNtpOxTqEoUhGdAakxdG6MOpHJTTtmJqcsUNd7lDcop7ZTgcqf3Zz_03YDpd500F_0H4fPF7CvbKxS8czGJRRlto6ukJMlv9bW_Aa6wpE7
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Anti-tumor+agent+comprising+cytidine+derivative+and+carboplatin&rft.inventor=KAZUNO+HIROMI&rft.date=2013-11-19&rft.externalDBID=B2&rft.externalDocID=US8586561B2